All published articles of this journal are available on ScienceDirect.
Management of Cardiac Involvement in NeuroMuscular Diseases: Review
Rachida Bouhouch, *
Tarik Elhouari
Latifa Oukerraj
Ibtissam Fellat
Jamila Zarzur
Rajaa Bennani
Mhamed Arharbi
Authors Info & Affiliations
Tarik Elhouari
Latifa Oukerraj
Ibtissam Fellat
Jamila Zarzur
Rajaa Bennani
Mhamed Arharbi
Authors Info & Affiliations
The Open Cardiovascular Medicine Journal
•
22 Oct 2008 •
REVIEW ARTICLE
•
DOI: 10.2174/1874192400802010093
Abstract
Neuromuscular Diseases are a heterogeneous molecular, clinical and prognosis group. Progress has been achieved in the understanding and classification of these diseases.
Cardiac involvement in neuromuscular diseases namely conduction disorders, ventricular dilatation and dilated cardiomyopathy with its impact on prognosis, is often dissociated from the peripheral myopathy. Therefore, close surveillance is mandatory in the affected patients. In this context, preventive therapy (beta-blockers and angiotensin converting enzyme inhibitors) has been recently recommended in the most common Neuromuscular Diseases, Duchenne Muscular Dystrophy and Myotonic Dystrophy.
Key Words: Muscular dystrophy, cardiomyopathy, sudden cardiac death..